Latest News

  • 12 Apr 2021
    Oncurious NV Reports Encouraging Data from Phase 1 Dose Escalation Study of TB-403 in Paediatric Subjects with Relapsed or Refractory Medulloblastoma Presented at the American Association for Cancer Research 2021 Annual Meeting
  • 9 Apr 2021
    ONCURIOUS Presenting Clinical and Preclinical Data at Upcoming American Association for Cancer Research (AACR) 2021 Annual Meeting
  • 24 Feb 2021
    Oncurious Announces Publication in Journal for Immunotherapy of Cancer highlighting the efficacy and safety of targeting CCR8 for the depletion of tumor-promoting Tumor Infiltrating Tregs in combination with anti-PD-1 therapy
  • 22 Oct 2020
    ONCURIOUS NV Announces First Preclinical Proof of Concept in Proprietary CCR8 Treg Program
  • 11 Jun 2019
    ONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer Immunotherapies

Stay up to date on the latest developments at Oncurious. Be sure to check in regularly for updates and press releases on ongoing research and clinical trials or just subscribe to our mailing list to receive regular updates.